Overview Avanz Phleum Pratense Maintenance Dose Status: Completed Trial end date: 2013-01-01 Target enrollment: Participant gender: Summary The purpose of the trial is to evaluate the efficacy of two dosing schedules of Avanz SQ+ (Standardised Quality) Phleum pratense compared to placebo in subjects with grass pollen induced allergic rhinoconjunctivitis with or without asthma. Phase: Phase 2/Phase 3 Details Lead Sponsor: ALK-Abelló A/S